These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 27881684)

  • 21. Epitope mapping of anti-interleukin-13 neutralizing antibody CNTO607.
    Teplyakov A; Obmolova G; Wu SJ; Luo J; Kang J; O'Neil K; Gilliland GL
    J Mol Biol; 2009 May; 389(1):115-23. PubMed ID: 19361524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thermostable designed ankyrin repeat proteins (DARPins) as building blocks for innovative drugs.
    Schilling J; Jost C; Ilie IM; Schnabl J; Buechi O; Eapen RS; Truffer R; Caflisch A; Forrer P
    J Biol Chem; 2022 Jan; 298(1):101403. PubMed ID: 34793836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Designed ankyrin repeat proteins as anti-idiotypic-binding molecules.
    Vogel M; Keller-Gautschi E; Baumann MJ; Amstutz P; Ruf C; Kricek F; Stadler BM
    Ann N Y Acad Sci; 2007 Aug; 1109():9-18. PubMed ID: 17785285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DARPins: a true alternative to antibodies.
    Stumpp MT; Amstutz P
    Curr Opin Drug Discov Devel; 2007 Mar; 10(2):153-9. PubMed ID: 17436550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crystal structures of HER3 extracellular domain 4 in complex with the designed ankyrin-repeat protein D5.
    Radom F; Vonrhein C; Mittl PRE; Plückthun A
    Acta Crystallogr F Struct Biol Commun; 2021 Jul; 77(Pt 7):192-201. PubMed ID: 34196609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specific targeting of human caspases using designed ankyrin repeat proteins.
    Flütsch A; Schroeder T; Barandun J; Ackermann R; Bühlmann M; Grütter MG
    Biol Chem; 2014 Oct; 395(10):1243-52. PubMed ID: 25153593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural and functional analysis of phosphorylation-specific binders of the kinase ERK from designed ankyrin repeat protein libraries.
    Kummer L; Parizek P; Rube P; Millgramm B; Prinz A; Mittl PR; Kaufholz M; Zimmermann B; Herberg FW; Plückthun A
    Proc Natl Acad Sci U S A; 2012 Aug; 109(34):E2248-57. PubMed ID: 22843676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rigid fusions of designed helical repeat binding proteins efficiently protect a binding surface from crystal contacts.
    Ernst P; Honegger A; van der Valk F; Ewald C; Mittl PRE; Plückthun A
    Sci Rep; 2019 Nov; 9(1):16162. PubMed ID: 31700118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specific inhibition of caspase-3 by a competitive DARPin: molecular mimicry between native and designed inhibitors.
    Schroeder T; Barandun J; Flütsch A; Briand C; Mittl PR; Grütter MG
    Structure; 2013 Feb; 21(2):277-89. PubMed ID: 23333429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Designed ankyrin repeat proteins (DARPins): binding proteins for research, diagnostics, and therapy.
    Plückthun A
    Annu Rev Pharmacol Toxicol; 2015; 55():489-511. PubMed ID: 25562645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Half-life extension using serum albumin-binding DARPin® domains.
    Steiner D; Merz FW; Sonderegger I; Gulotti-Georgieva M; Villemagne D; Phillips DJ; Forrer P; Stumpp MT; Zitt C; Binz HK
    Protein Eng Des Sel; 2017 Sep; 30(9):583-591. PubMed ID: 29088432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo binding and retention of CD4-specific DARPin 57.2 in macaques.
    Pugach P; Krarup A; Gettie A; Kuroda M; Blanchard J; Piatak M; Lifson JD; Trkola A; Robbiani M
    PLoS One; 2010 Aug; 5(8):e12455. PubMed ID: 20805996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selection, purification, and characterization of a HER2-targeting soluble designed ankyrin repeat protein by E. coli surface display using HER2-positive melanoma cells.
    Chen X; Yu X; Song X; Liu L; Yi Y; Yao W; Gao X
    Prep Biochem Biotechnol; 2018 Feb; 48(2):144-150. PubMed ID: 29313422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Orthogonal assembly of a designed ankyrin repeat protein-cytotoxin conjugate with a clickable serum albumin module for half-life extension.
    Simon M; Frey R; Zangemeister-Wittke U; Plückthun A
    Bioconjug Chem; 2013 Nov; 24(11):1955-66. PubMed ID: 24168270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design and characterization of MP0250, a tri-specific anti-HGF/anti-VEGF DARPin® drug candidate.
    Binz HK; Bakker TR; Phillips DJ; Cornelius A; Zitt C; Göttler T; Sigrist G; Fiedler U; Ekawardhani S; Dolado I; Saliba JA; Tresch G; Proba K; Stumpp MT
    MAbs; 2017; 9(8):1262-1269. PubMed ID: 29035637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rigidly connected multispecific artificial binders with adjustable geometries.
    Wu Y; Batyuk A; Honegger A; Brandl F; Mittl PRE; Plückthun A
    Sci Rep; 2017 Sep; 7(1):11217. PubMed ID: 28894181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Designed ankyrin repeat proteins (DARPins) from research to therapy.
    Tamaskovic R; Simon M; Stefan N; Schwill M; Plückthun A
    Methods Enzymol; 2012; 503():101-34. PubMed ID: 22230567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, Characterization, and Selective Delivery of DARPin-Gold Nanoparticle Conjugates to Cancer Cells.
    Deyev S; Proshkina G; Ryabova A; Tavanti F; Menziani MC; Eidelshtein G; Avishai G; Kotlyar A
    Bioconjug Chem; 2017 Oct; 28(10):2569-2574. PubMed ID: 28806065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rigidity of the extracellular part of HER2: Evidence from engineering subdomain interfaces and shared-helix DARPin-DARPin fusions.
    Jost C; Stüber JC; Honegger A; Wu Y; Batyuk A; Plückthun A
    Protein Sci; 2017 Sep; 26(9):1796-1806. PubMed ID: 28639341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Destabilizing an interacting motif strengthens the association of a designed ankyrin repeat protein with tubulin.
    Ahmad S; Pecqueur L; Dreier B; Hamdane D; Aumont-Nicaise M; Plückthun A; Knossow M; Gigant B
    Sci Rep; 2016 Jul; 6():28922. PubMed ID: 27380724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.